SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,535.97 |
| Enterprise Value ($M) | 1,209.97 |
| Book Value ($M) | 373.50 |
| Book Value / Share | 5.82 |
| Price / Book | 4.11 |
| NCAV ($M) | 201.42 |
| NCAV / Share | 3.14 |
| Price / NCAV | 7.63 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.39 |
| Return on Assets (ROA) | -0.26 |
| Return on Equity (ROE) | -0.37 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.45 |
| Current Ratio | 3.45 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 570.94 |
| Assets | 743.03 |
| Liabilities | 369.53 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 207.54 |
| Operating Income | -209.30 |
| Net Income | -187.12 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -157.37 |
| Cash from Investing | 148.84 |
| Cash from Financing | 10.12 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Rubric Capital Management LP | 7.85 | 35.67 | |
| 13G | Sumitomo Mitsui Trust Holdings, Inc. | 5.50 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 265,287 | 969,884 | 27.35 | |
| 715,686 | 2,181,362 | 32.81 | |
| 169,259 | 890,483 | 19.01 | |
| 255,155 | 1,286,431 | 19.83 | |
| 181,688 | 902,815 | 20.12 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RXRX – Recursion Pharmaceuticals, Inc. | SANA – Sana Biotechnology, Inc. |
| SCPH – scPharmaceuticals Inc. | SLDB – Solid Biosciences Inc. |
| SLRN – Acelyrin, Inc. |
Financial data and stock pages provided by
Fintel.io